Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis
Metabolic-associated fatty liver disease (MAFLD) and its potential impact on the severity of COVID-19 have gained significant attention during the pandemic. This review aimed to explore the genetic determinants associated with MAFLD, previously recognized as non-alcoholic fatty liver disease (NAFLD)...
Main Authors: | Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Sandor G. Vari, Aleksandr Kamyshnyi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-08-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/8/1724 |
Similar Items
-
Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study
by: Mykhailo Buchynskyi, et al.
Published: (2024-01-01) -
The structure of Haplotypes and Diplotypes in the PNPLA3 gene in the Yakut Population
by: Khariton A. Kurtanov, et al.
Published: (2020-12-01) -
MAFLD: How is it different from NAFLD?
by: Cameron Gofton, et al.
Published: (2023-02-01) -
The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
by: Mykhailo Buchynskyi, et al.
Published: (2023-04-01) -
PNPLA3—A Potential Therapeutic Target for Personalized Treatment of Chronic Liver Disease
by: Xiaocheng Charlie Dong
Published: (2019-12-01)